Carina Lorenz

Kerpener Str. 62
Koeln, NW 50937, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Histo-Miner: Deep learning based tissue features extraction pipeline from H&E whole slide images of cutaneous squamous cell carcinoma.

Histo-Miner: Deep learning based tissue features extraction pipeline from H&E whole slide images of cutaneous squamous cell carcinoma.

Journal: PLoS computational biology

Published: August 06, 2025

Explainable, federated deep learning model predicts disease progression risk of cutaneous squamous cell carcinoma.

Explainable, federated deep learning model predicts disease progression risk of cutaneous squamous cell carcinoma.

Journal: NPJ precision oncology

Published: November 13, 2024

Predicting the next move: tracking the complexity of lung cancer evolution and metastasis.

Predicting the next move: tracking the complexity of lung cancer evolution and metastasis.

Journal: Signal transduction and targeted therapy

Published: May 15, 2023

Characterizing Evolutionary Dynamics Reveals Strategies to Exhaust the Spectrum of Subclonal Resistance in EGFR-Mutant Lung Cancer.

Characterizing Evolutionary Dynamics Reveals Strategies to Exhaust the Spectrum of Subclonal Resistance in EGFR-Mutant Lung Cancer.

Journal: Cancer research

Published: August 17, 2022

Insight into Targeting Exon20 Insertion Mutations of the Epidermal Growth Factor Receptor with Wild Type-Sparing Inhibitors.

Insight into Targeting Exon20 Insertion Mutations of the Epidermal Growth Factor Receptor with Wild Type-Sparing Inhibitors.

Journal: Journal of medicinal chemistry

Published: April 29, 2022

CD74-NRG1 Fusions Are Oncogenic In Vivo and Induce Therapeutically Tractable ERBB2:ERBB3 Heterodimerization.

CD74-NRG1 Fusions Are Oncogenic In Vivo and Induce Therapeutically Tractable ERBB2:ERBB3 Heterodimerization.

Journal: Molecular cancer therapeutics

Published: October 05, 2021

MAPK-pathway inhibition mediates inflammatory reprogramming and sensitizes tumors to targeted activation of innate immunity sensor RIG-I.

MAPK-pathway inhibition mediates inflammatory reprogramming and sensitizes tumors to targeted activation of innate immunity sensor RIG-I.

Journal: Nature communications

Published: November 25, 2020

MYC paralog-dependent apoptotic priming orchestrates a spectrum of vulnerabilities in small cell lung cancer.

MYC paralog-dependent apoptotic priming orchestrates a spectrum of vulnerabilities in small cell lung cancer.

Journal: Nature communications

Published: November 30, 2018

Structural Alterations of MET Trigger Response to MET Kinase Inhibition in Lung Adenocarcinoma Patients.

Structural Alterations of MET Trigger Response to MET Kinase Inhibition in Lung Adenocarcinoma Patients.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 10, 2017

Systematic Kinase Inhibitor Profiling Identifies CDK9 as a Synthetic Lethal Target in NUT Midline Carcinoma.

Systematic Kinase Inhibitor Profiling Identifies CDK9 as a Synthetic Lethal Target in NUT Midline Carcinoma.

Journal: Cell reports

Published: February 17, 2017

Drugging the catalytically inactive state of RET kinase in RET-rearranged tumors.

Drugging the catalytically inactive state of RET kinase in RET-rearranged tumors.

Journal: Science translational medicine

Published: July 21, 2016

Showing 1-11 of 11

Last Updated: 09/26/2026